Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LEAD COVID-19: Aspirin and Vitamin D for COVID-19
NCT04363840Phase 2Withdrawn
- Sponsor
- Louisiana State University Health Sciences Center
- Start
- May 2020
- Primary completion
- Dec 2020
- Modality
- Orthosteric Ligands
01
Overview
A Phase 2 trial of aspirin in coronavirus disease 2019 (COVID-19), sponsored by Louisiana State University Health Sciences Center. Planned start May 2020; status: withdrawn.
02
Drugs
aspirin
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04363840.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04363840.